Merck & Co.

MRK is the ticker symbol for Merck & Co., a company classified under the Pharmaceuticals industry within the broader Health Care sector.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Key metrics include a return on equity of -9.2%.

The company reports trailing twelve-month revenue of $16.29B and net loss of $4.24B.

FINOTAUR aggregates real-time and fundamental data on MRK to help traders and investors make informed decisions. Track MRK in your trading journal alongside other positions for a unified view of your portfolio.